Skip to content

Clinical trials

Metabolic Diseases trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: India Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20095
20102
20111
20121
20171
20183
20201
20223
20231
20245
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting4
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
AstraZeneca4
89bio, Inc.3
CENTOGENE GmbH Rostock3
Centre for Chronic Disease Control, India2
Regeneron Pharmaceuticals2
Bayer1
GEM Hospital & Research Center1
Ionis Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases27
Diabetes Mellitus, Type 212
Diabetes Mellitus9
Glucose Metabolism Disorders9
Endocrine System Diseases8
Genetic Diseases, Inborn4
Lipid Metabolism Disorders3
Liver Diseases3
Lysosomal Storage Diseases3
Metabolism, Inborn Errors3

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.